SCHEMBL12711925

SCHEMBL12711925

CC(C)Nc1nc(C(C)C)nc2[nH]ncc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.38
▸ PDPK1 O15530 1/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ MAPK14 Q16539 1/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ JAK1 P23458 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ HTR2C P28335 2/20 0.35
▸ CXCR2 P25025 1/20 0.35
▸ PLK4 O00444 1/20 0.35
▸ PAK4 O96013 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ APP P05067 1/20 0.34
▸ LATS1 O95835 1/20 0.33
▸ LATS2 Q9NRM7 1/20 0.33
▸ MKNK1 Q9BUB5 1/20 0.33
▸ HPGDS O60760 1/20 0.33
▸ ACP1 P24666 1/20 0.33
▸ BTK Q06187 1/20 0.33
▸ AURKA O14965 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12963988 0.81 USP2 (0.39) ALDH1A1PDPK1CYP1A2MAPK14JAK2
SCHEMBL24174703 0.76 RET (0.47) ALDH1A1PDPK1CYP1A2MKNK1AURKA
SCHEMBL11617352 0.76 ALDH1A1 (0.40) ALDH1A1PDPK1CYP1A2JAK2JAK1
SCHEMBL12711931 0.73 JAK2 (0.39) JAK2JAK3CXCR2APPACP1
SCHEMBL24995637 0.73 ALDH1A1 (0.38) ALDH1A1PDPK1CYP1A2HTR2CHTR2A
SCHEMBL10094121 0.72 PDPK1 (0.66) ALDH1A1PDPK1CYP1A2MKNK1HPGDS
SCHEMBL801835 0.71 LATS1 (0.35) ALDH1A1APPLATS1LATS2ACP1
SCHEMBL12711905 0.68 SLC29A1 (0.32) —
SCHEMBL12711803 0.68 APP (0.66) ALDH1A1APPACP1AURKAAURKB
SCHEMBL801420 0.68 APP (0.42) JAK2JAK1JAK3APPLATS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8669081-B2 Compositions useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-03-11 — — US disclosed
US-20110086856-A1 COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-04-14 — — US disclosed
US-20110086856-A1 COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-04-14 — — US disclosed
US-7863282-B2 Compositions useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-01-04 — — US disclosed
US-20070190634-A1 Compositions useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED 2007-08-16 — — US disclosed
US-20070179133-A1 Compositions useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED 2007-08-02 — — US disclosed
US-7179826-B2 Compositions useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-02-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179133-A1 Compositions useful as inhibitors of protein kinases MAP3K20, PACSIN2, MAP3K6 ALDH1A1 4661/4885PDPK1 123/4885CYP1A2 4716/4885
US-20110086856-A1 COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES MAP3K20, PACSIN2, MAP3K6 ALDH1A1 4661/4885PDPK1 123/4885CYP1A2 4716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback